ESC Premium Access

A deeper dive into key ODYSSEY OUTCOMES results and their impact on patient management.

Congress Presentation

About the speaker

Professor Gregory Schwartz

University of Colorado School of Medicine, Aurora (United States of America)
2 presentations
0 follower

2 more presentations in this session

From identification of high CV risk patients to treatment with PCSK9i: learnings from ODYSSEY OUTCOMES.

Speaker: Professor A. Zeiher (Frankfurt, DE)


Interaction with the audience

Speaker: Professor A. Zeiher (Frankfurt, DE)


Access the full session

From ODYSSEY OUTCOMES results to clinical practice - Identifying patients who may benefit most from PCSK9 inhibition

Speakers: Professor G. Schwartz, Professor A. Zeiher, Professor A. Zeiher

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb